Earlier quoted context omitted.
I loved this post (basically a balanced criticism of psychiatry by a psychiatrist), and I think it makes a great HN submission .
I actually think it's worth taking the time to break down what makes something a good or bad HN submission. Some elements present in this piece that, when combined , seem to drive the worst kinds of HN threads: * A spicy take * A subject almost no likely commenters have any expertise on * A subject that lots of likely commenters have their own spicy takes on * Invocation of "wokeness" * Perennial HN punching bag targ…
The APA Meeting: A Photo-Essay
31–35 of 35 posts
Re: The APA Meeting: A Photo-Essay
#32Re: The APA Meeting: A Photo-Essay
#33There's illumination here for those of us who've been prescribed shockingly expensive drugs with generic near-equivalents going for 1/40th the price (as I have): >I asked the Lucemyra® representative why I might prescribe Lucemyra® instead of clonidine for opiate withdrawal. She said it was because Lucemyra® is FDA-approved for this indication, and clonidine isn’t. This is the same old story as Rozerem® vs. melatonin…
Yes, the long-term effects of taking ketamine frequently are not well understood. In my opinion a patient with TRD should be allowed to take this risk provided that they have tried several other drugs.
Re: The APA Meeting: A Photo-Essay
#34There's illumination here for those of us who've been prescribed shockingly expensive drugs with generic near-equivalents going for 1/40th the price (as I have): >I asked the Lucemyra® representative why I might prescribe Lucemyra® instead of clonidine for opiate withdrawal. She said it was because Lucemyra® is FDA-approved for this indication, and clonidine isn’t. This is the same old story as Rozerem® vs. melatonin…
There's also illumination for people who are interested in the debate on whether or not one should research medical issues on the internet yourself, or "trust your doctor, they're a professional".
Re: The APA Meeting: A Photo-Essay
#35It's kind of horrifying to consider that advertising has a statistically significant chance of influencing a psychiatrist away from prescribing based on what best suits the indication.